Blocking Flu Death

Researchers have identified the cellular regulators of cytokine storms in influenza, which cause serious illness and death.

Written byTia Ghose
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Victims of the 1918 influenza housed in Camp Funston, KansasWIKIMEDIA COMMONS, US ARMY PHOTOGRAPHER

Researchers have identified a receptor that can block the flooding of immune cells into infected tissue that causes deadly bouts of the flu. The findings, published today (September 15) in Cell, could one day be used to develop treatments for people who are vulnerable to getting very sick from the flu.

“This was a hugely complex and very complete study,” said Herbert “Skip” Virgin, a viral immunologist at Washington University Medical School in St. Louis, who was not involved in the study. What’s exciting is that “there’s a specific pharmacologic inhibitor molecule that can be targeted to improve clinical outcome in influenza.” The new approach is unique, he added, because it targets the reaction of the host, rather than characteristics of the virus, which can ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies